Testicular Cancer

CDC: Cancer Prevention Services Below Target Goals

CDC: Cancer Prevention Services Below Target Goals

Increasing health insurance coverage and access to usual source of care necessary to meet targets.

Patients Misinformed About Their Risk of Cancer

Patients Misinformed About Their Risk of Cancer

Seventeen percent of Americans think that there is nothing people can do to change their risk.

Prostate Cancer Still a Leading Cause of Cancer Deaths

Prostate Cancer Still a Leading Cause of Cancer Deaths

By

Death from PCa is down 45% from peak rates, but more than 29,000 men are projected to die from PCa in 2014.

New Ablative Techniques in Urologic Oncology

Innovative approaches offer the potential for effective treatments to limited target 
areas with improved side effect profiles.

Survey: Docs Not Discussing Cancer Screening Risks with Patients

By

Only 9.5% of the study participants were told about the possibilities of overdiagnosis and overtreatment by their physicians.

Few Patients Informed About Risks of Cancer Overdiagnosis

Few Patients Informed About Risks of Cancer Overdiagnosis

Most want to be told of screening harms, but only 9.5 percent informed about overdiagnosis, overtx.

Adding Chemo to Radiotherapy Aids Testicular Cancer Treatment

By

Giving men a single dose of chemotherapy along with radiotherapy may help improve the effectiveness of treatment.

Cancer More Likely in Azoospermic Men

By

Azoospermic men may be nearly three times as likely to receive a diagnosis of cancer as men in the overall population.

Rate of Nephrectomy at Lymph Node Dissection Is Declining

Rate of Nephrectomy at Lymph Node Dissection Is Declining

Study attributes this to greater understanding of pathology, increased surveillance.

Undescended Testes Raise Testicular Cancer Risk

By

The malignancy is three times more likely to develop in boys with cryptorchidism.

Testicular Cancer, Pot Smoking Linked

By

Those who had ever smoked marijuana were almost twice as likely as non-users of marijuana to develop the disease.

Radiotherapy Relapse Rare in Stage II Testicular Seminoma

Radiotherapy Relapse Rare in Stage II Testicular Seminoma

By

The relapse-free survival at 10 years was 83% and 54% for stage IIA and IIB patients, respectively.

Marijuana Use Linked to Higher Risk of Testicular Cancer

Marijuana Use Linked to Higher Risk of Testicular Cancer

Risk highest for nonseminoma and mixed histology tumors.

Late Puberty Lowers Testicular Cancer Risk

By

Researchers believe their findings suggest post-natal risk factors modify testicular cancer risk.

Platinum Treatment for Testicular Cancer Increases Neurotoxicity

Platinum Treatment for Testicular Cancer Increases Neurotoxicity

Long-term serum levels of residual platinum correlate with the severity of neurotoxicity five to 20 years after chemotherapy in testicular cancer (TC) survivors, even after adjusting for initial cisplatin dose, according to a study published online in the Journal of Clinical Oncology.

Frequent CT Scanning for Testicular Cancer Surveillance Associated With Secondary Malignancies

By

Frequent CT scanning for testicular cancer surveillance appears to be associated with secondary malignancies.

Testicular Cancer Treatments May Incur Risks

By

CHICAGO—Testicular cancer survivors treated with chemotherapy and radiotherapy are at increased risk for cardiovascular disease (CVD), researchers reported at the American Society of Clinical Oncology annual meeting. These patients also are at higher risk for hypertension and diabetes.

Marijuana Use May Increase Risk of Testicular Cancer

By

Marijuana use may increase a man's risk of testicular cancer, particularly the nonseminona or mixed-histology form, according to a study published in Cancer (2009; published online ahead of print).

Sign Up for Free e-newsletters